Sanna Alice, Lambert Yann, Pelleau Stéphane, Musset Lise, Lazrek Yassamine, Hureau Louise, Cairo Hedley, Vreden Stephen, White Michael, Douine Maylis
Centre d'Investigation Clinique (Inserm 1424), Institut Santé des Populations en Amazonie, Centre Hospitalier de Cayenne, Cayenne, French Guiana.
Infectious Disease Epidemiology and Analytics, Institut Pasteur, Université Paris Cité, Paris, France.
Infect Dis Poverty. 2025 May 26;14(1):40. doi: 10.1186/s40249-025-01306-8.
The final challenge for malaria elimination in many countries is to interrupt the circulation of Plasmodium vivax. Given the unique biology of this parasite, innovative approaches are imperative, with a focus on identifying asymptomatic carriers of dormant parasite forms. This article delineates the recent epidemiological patterns of P. vivax malaria within a highly mobile and hard-to-reach population in the Guiana Shield. It further proposes an assessment of the potential reservoir of asymptomatic carriers.
This analysis was based on data from: (i) two cross-sectional surveys carried out at the French-Surinamese border in 2015 and 2019, including adults returning from gold mining sites located in French Guiana (FG), [questionnaires and blood samples, tested for polymerase chain reaction (PCR) and P. vivax serological exposure markers (SEM) of recent infection]; (ii) epidemiological malaria surveillance system in Suriname, including cases imported from gold mining sites located in western FG between 2014 and 2020. Factors associated with P. vivax seropositivity were analysed by multiple logistic regression. The probability of carrying P. vivax parasites (blood-stage or hypnozoite) was estimated by a classification drawn from PCR results, SEM and reported recent history of illness.
Surveillance data showed a decrease in malaria imported cases from French Guiana between beginning and end of the analysed period (236 in 2014 to 74 in 2020) and an increase in the proportion of cases associated with P. vivax (52.4% in 2014 to 100% in 2020). The PCR-prevalence of P. vivax in survey samples decreased from 11.4% in 2015 to 4.0% in 2019; P. vivax seropositivity decreased from 44.7% to 28.4%. P. vivax seropositivity was positively associated with male sex, age and number of years spent in gold mining, type of activity, and reported malaria history (episode within less than nine months OR = 10.73, 95% CI: 5.87-19.6, or history of repeated older episodes OR = 5.31, 95% CI: 3.13-9.01).
Our analysis shows an epidemiological evolution typical of a scenario of decreasing malaria circulation. Nevertheless, in 2020, gold miners in western FG still showed a moderate level of P. vivax circulation. Biological methods and epidemiological criteria can help to select potential parasite carriers, who could benefit from targeted drug administration.
在许多国家,消除疟疾的最后一项挑战是阻断间日疟原虫的传播。鉴于这种寄生虫独特的生物学特性,必须采取创新方法,重点是识别潜伏寄生虫形式的无症状携带者。本文描述了圭亚那地盾地区流动性高且难以到达的人群中间日疟原虫疟疾的近期流行病学模式。它还提议对无症状携带者的潜在储存库进行评估。
该分析基于以下数据:(i)2015年和2019年在法属圭亚那与苏里南边境进行的两项横断面调查,包括从法属圭亚那(FG)金矿返回的成年人[进行问卷调查并采集血样,检测聚合酶链反应(PCR)和近期感染的间日疟原虫血清学暴露标志物(SEM)];(ii)苏里南的疟疾流行病学监测系统,包括2014年至2020年期间从FG西部金矿输入的病例。通过多因素逻辑回归分析与间日疟原虫血清阳性相关的因素。根据PCR结果、SEM以及报告的近期患病史进行分类,估计携带间日疟原虫寄生虫(血期或休眠子)的概率。
监测数据显示,在分析期开始至结束期间,从法属圭亚那输入的疟疾病例有所减少(2014年为236例,2020年为74例),而与间日疟原虫相关的病例比例有所增加(2014年为52.4%,2020年为100%)。调查样本中间日疟原虫的PCR流行率从2015年的11.4%降至2019年的4.0%;间日疟原虫血清阳性率从44.7%降至28.4%。间日疟原虫血清阳性与男性、年龄、在金矿工作的年限、活动类型以及报告的疟疾病史呈正相关(9个月内发作OR = 10.73,95%CI:5.87 - 19.6,或既往多次发作病史OR = 5.31,95%CI:3.13 - 9.01)。
我们的分析显示出疟疾传播减少情况下典型的流行病学演变。然而,2020年,FG西部的金矿工人中间日疟原虫的传播仍处于中等水平。生物学方法和流行病学标准有助于选择可能从靶向药物给药中受益的潜在寄生虫携带者。